COMMITMENTS AND CONTINGENCIES (Details Textual)	1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 29, 2016 USD ($)	Mar. 31, 2014 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
COMMITMENTS AND CONTINGENCIES [Line Items]
Other Research And Development And General And Administration Expenses			$ 234,322	$ 149,174
Minimum [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Percentage of Royalty Payment			8.00%
Maximum [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Percentage of Royalty Payment			9.00%
Milestone Payment One [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Other Commitment, Total			$ 5,000,000
Milestone Payment Two [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Other Commitment, Total			20,000,000
Cambridge Major Laboratories Agreement [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Manufacturing Costs			$ 375,000
Subsequent Event [Member] | Columbia University Agreement [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Non Refundable Start Up Fees	$ 23,000
Patient Enrollment Fees	$ 15,000
Number Of Patients	30
Other Pass Through Costs	$ 30,000
Additional Fee Per Patient	$ 4,600
Anticipated Screen Failure Rate	25.00%
A5 Genetics KFT [Member]
COMMITMENTS AND CONTINGENCIES [Line Items]
Cost of Services, Licenses and Services					$ 100,000
Additional License Fee Amount Paid		$ 100,000
Additional License Fee Obligation Amount		1,200,000
Royalty Expense		50
Cost of Services		$ 65